Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise-The Energy Report (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

I See Dead Stocks

% of readers think this story is Fact. Add your two cents.


Source: Stephen McBride 09/08/2025

Stephen McBride of RiskHedge explains why he thinks investing in the hottest stocks might not be your best bet.

“I see dead people.”

That memorable line from The Sixth Sense ranks among the most recognizable movie quotes ever.

Well, to brazenly borrow that phrase . . . “I see dead stocks.”

And I’m spotting them in some of today’s most sizzling industries, including nuclear, robotics, and drones.

Folks rushing to grab shares in these sectors are committing a massive blunder.

  • Drones are revolutionizing warfare right in front of us.

More than 70% of casualties in Ukraine stem from lethal airborne machines.

That’s partly why drone manufacturer AeroVironment Inc. (AVAV:NASDAQ) has jumped over 100% during the past five months.

Drones = game-changing?

Yes.

Drone stocks = smart investment?

No.

AeroVironment’s aerial vehicles are cumbersome with fixed wings. They’re designed for an outdated era when unmanned aircraft primarily conducted long-range surveillance. And each Switchblade unit runs upwards of $50,000.

Meanwhile, the flying gadgets reshaping Ukrainian battlefields are compact quadcopters priced as low as $1,000.

Upstarts like Neros and Flyby Robotics are crafting drones that are tinier, more affordable, and more intelligent. They can operate in groups, navigate autonomously, and be mass-produced at significantly lower costs.

I’ve been fortunate to speak with founders leading this next wave of drone ventures. Many have already deployed their technology in Ukraine and beyond. These conversations quickly reveal that established manufacturers like AeroVironment are doomed.

Inexpensive, adaptable drones represent the future. That’s what military forces will purchase.

  • Some of today’s most popular stocks are . . .

Companies that are developing a fresh category of compact nuclear reactors (SMRs).

AeroVironment Inc. (AVAV:NASDAQ) has soared threefold this year. NuScale Power Corp. (SMR:NYSE) has increased twofold.

You won’t encounter a stronger advocate for nuclear energy than me. I initially wrote about capitalizing on nuclear back in 2018, suggesting Cameco Corp. (CCO:TSX; CCJ:NYSE).

The stock has rocketed 580% since then:

Microreactors from Oklo and NuScale are pioneering nuclear energy’s future. They’ll enhance the world’s safest, cleanest, most dependable power source even further.

Oklo, NuScale, and NANO Nuclear Energy Inc. (NNE:NASDAQ) may be the only publicly traded SMR businesses. But they won’t emerge victorious in the SMR competition.

During the last year, I’ve toured facilities of several prominent microreactor startups, including Valar Atomics and Aalo Atomics. I’ve conversed with numerous other founders.

These agile newcomers will thoroughly outperform the more sluggish Oklo and NuScale.

Where’s the evidence?

NuScale’s flagship development in Idaho was supposed to be the world’s inaugural SMR. But it collapsed last year after expenses nearly doubled to $9.3 billion. This followed burning through 2 million engineering hours and $500 million solely on licensing documentation.

Meanwhile, Valar, Aalo, and others are rushing to activate America’s first SMR by Independence Day, 2026.

  • Something always seemed “strange” about robotics investments.

I’d constantly hear robots were conquering the world and appearing everywhere. . .

Yet, examining the financial statements of major robotics corporations revealed minimal growth.

Strange, right?

Robotaxi pioneer Waymo recently achieved the landmark of 100 million fully self-driving miles on American roadways.

Aerial delivery startups like Zipline are transporting burritos (and everything else) to satisfied customers nationwide.

Amazon.com Inc. (AMZN:NASDAQ) now utilizes more robots than human workers in its distribution centers!

You can acknowledge robotics is transforming industries while simultaneously recognizing that investing in industrial automation giants like ABB Ltd. (ABBNY:OTCMKTS; ABB:ST), FANUC Corp. (FANUY:OTCMKTS), and Yaskawa Electric Corp. (YASKY:OTCMKTS) is misguided.

These represent the largest robotics enterprises globally. By default, they’re viewed as industry leaders.

But when conversing with startups at robotics’ cutting edge, you discover a little secret:

These are industrial fossils.

The genuine future is being constructed by ventures creating artificial intelligence (AI)-native machines.

Units that master tasks in hours, not months. And that can “upgrade” similar to your iPhone.

Once these robotics newcomers scale production, the old guard will be flattened.

  • “Fine, Stephen. So which shares should I acquire?”

To quote Kenny Rogers, “You’ve got to know when to hold ‘em, know when to fold ‘em.”

The premier drone, nuclear, and robotics organizations aren’t publicly listed yet.

And that’s beneficial.

These are early-phase ventures that shouldn’t need to worry about continuous public market scrutiny.

But if you possess legacy investments across these disruptive sectors, I suggest folding ‘em.

These stocks might continue rising as investors grow enthusiastic about drones, robotics, and nuclear reshaping our world.

But they’re not the enduring champions.

I see dead stocks.

P.S. A lot of investors get stuck looking back at stocks that have worked well in the past.

But in The Jolt, I look to the future . . . and the promising companies making technologies that will move markets over the next decade.

If you’d like to join me, you can sign up here to start receiving The Jolt for free.

[SMNLINSERT]

Important Disclosures:

  1. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Cameco Corp.
  2. Stephen McBride: I, or members of my immediate household or family, own securities of: None. My company has a financial relationship with: None. My company has purchased stocks mentioned in this article for my management clients: None. I determined which companies would be included in this article based on my research and understanding of the sector.
  3. Statements and opinions expressed are the opinions of the author and not of Streetwise Reports, Street Smart, or their officers. The author is wholly responsible for the accuracy of the statements. Streetwise Reports was not paid by the author to publish or syndicate this article. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Any disclosures from the author can be found below. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
  4. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

( Companies Mentioned: ABBNY:OTCMKTS;ABB:ST, AVAV:NASDAQ, AMZN:NASDAQ, CCO:TSX; CCJ:NYSE, FANUY:OTCMKTS, NNE:NASDAQ, SMR:NYSE, YASKY:OTCMKTS, )


Source: https://www.streetwisereports.com/article/2025/09/08/i-see-dead-stocks.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login